Author: Haviv Y.S. Friedlaender M. Dranitzki-Elhallel M.
Publisher: Adis International
ISSN: 1173-2563
Source: Clinical Drug Investigation, Vol.18, Iss.2, 1999-08, pp. : 169-172
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Peginterferon alfa 2b: Chronic inflammatory demyelinating polyneuropathy: case report
Reactions Weekly, Vol. 1, Iss. 1304, 2010-01 ,pp. :
Peginterferon-α-2a: Chronic inflammatory demyelinating polyneuropathy: case report
Reactions Weekly, Vol. 1, Iss. 1347, 2011-01 ,pp. :
Tacrolimus: Demyelinating sensorimotor polyneuropathy: case report
Reactions Weekly, Vol. 1, Iss. 1421, 2012-01 ,pp. :
Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Drugs, Vol. 63, Iss. 3, 2003-01 ,pp. :